Home | Business News | CBJ Newsmakers | BriaCell Announces Clinical Trial Collaboration Agreement with Incyte BriaCell Announces Clinical Trial Collaboration Agreement with Incyte CBJ Newsmakers RecommendedCN Issues Statement on STB DecisionSilver Mountain Mines Inc. Receives Conditional For Reverse Takeover Transaction With Nevgold Corp.Sandoz Canada launches its 6th biosimilar with Inclunox® and Inclunox® HP (Enoxaparin sodium solution for injection 100 mg/mL and 150 mg/mL (High Potency))
